KV Pharmaceutical - Makena™ (hydroxyprogesterone caproate injection) FDA Approval | FDA-Approved Makena
FDA-Approved Makena™ is indicated to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth.
Is this your site? Certify your site and update informations
